Two well-characterized conditions, in which the aberrant activity of the NLRP3 inflammasome contributes to and exacerbates pathology, leading to inflammaging, are obesity and diabetes. The gene discussed is NLRP3; the disease is obesity due to melanocortin 4 receptor deficiency.